GLICLAVAC MR 30

GLICLAVAC MR 30 contains Gliclazide 30 mg (Modified Release), an oral antidiabetic medication used for the management of type 2 diabetes mellitus. It belongs to the sulfonylurea class of drugs and helps control blood glucose levels by stimulating the pancreas to release insulin in a steady and controlled manner throughout the day. The modified-release formulation ensures long-lasting blood sugar control with fewer fluctuations.

Key Benefits:

• Provides effective and sustained blood sugar control.

• Helps manage type 2 diabetes mellitus.

• Modified-release formulation ensures convenience with once-daily dosing.

• Supports better compliance and stable glucose levels.